000			01347nam a2200121Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
100			_aLidbury, Brett||Fisher, Paul
245		0	_aBiomedical Insights that Inform the Diagnosis of ME/CFS
546			_aEnglish[eng]
650			_afatigue syndrome||n/a||work rehabilitation||tryptophan metabolism||substrate inhibition||myalgic encephalomyelitis||3-dioxygenase||ME (Myalgic Encephalomyelitis)||assessment||myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)||muscles||hypoacetylation||circadian rhythm||immune system||chronic||CFS (Chronic Fatigue Syndrome)||energy metabolism||ME/CFS||immunological||cytokine||bistability||diagnosis||biomarker||symptoms||kynurenine pathway||inflammation and immunity||metabolism||neuro-inflammation||pathology||signaling||exercise||Epstein Barr virus||methylhistidine||hypothalamic–pituitary–adrenal axis||potential biomarkers||critical point||inflammation||histone deacetylation||participatory research||neurology||neuroimmune||activin||mitochondria||patient-driven questionnaire||medical retirement||machine learning||prognosis||gut microbiota||post-exertional malaise||chronic fatigue syndrome||mathematical model||reference intervals||diagnostic biomarker||indoleamine-2
856			_uhttps://mdpi.com/books/pdfview/book/2100
942			_cEB
999			_c19188 _d19188